A former chief of staff to Deputy Prime Minister Richard Marles has resolved her case alleging she was forced out after complaints of bullying.
US lab products giant Beckman Coulter has successfully opposed an Australian biotech’s bid to trade mark ‘Cytophex’ for its stem cell expansion system, with an IP Australia delegate finding the mark is too similar to Beckman’s ‘CytoFLEX’ mark.
Payday lender Sunshine Loans has lost an appeal after it was ruled liable for “wrongheaded” conduct, with an appeals court finding that counsel showed an “egregious failure” to confine the case to the real issues.
The funder that backed a shareholder class action against engineering firm CIMIC that settled for $45.25 million will take a cut to its 25 per cent commission, but wants the court to find the commission would otherwise have been reasonable.
The federal government has launched a cross-claim against private security companies G4S and ACM in a class action on behalf of asylum seekers held in two immigration detention centres in South Australia.
Family-owned real estate group Coronis has successfully challenged the tax office on a $5 million alleged shortfall, with a judge finding service fees paid to two companies in the group were deductible.
A judge has refused a late-stage bid to strike out Brisbane Airport’s lawsuit against lessee AirServices Australia claiming $17.3 million in damage from PFAS contamination caused by its use of firefighting foam.
United Petroleum has successfully sued the landlords of one of its petrol stations for failing to pay for repairs to potholes described as “more like large craters”.
Another fight over an $87 million mixed-use Canberra development may be on the cards, after the project’s liquidators won approval to assign potential claims against WSP and builder Construction Control over alleged stitch bolt defects.
Pharmacor will be allowed to sell a generic version of heart drug Entresto after the Full Court rejected Swiss drug giant Novartis’ appeal of a ruling that found an extension of the term of its patent for the drug was invalidly granted.